Bullish (BLSH)

Intra-Cellular Therapies Revenue

Bullish had revenue of $80.26B in the quarter ending March 31, 2025, with 31,350,080.08% growth. This brings the company's revenue in the last twelve months to $250.11B. In the year 2024, Bullish had annual revenue of $250.26B with 114.80% growth.

• Revenue (ttm): $250.11B
• Revenue Growth: +114.80%
• P/S Ratio: 0.02
• Revenue / Employee: $625,264,418
• Employees: 400
• Market Cap: 5.41B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	250.26B	133.76B	114.80%
Dec 31, 2023	116.51B	43.61B	59.83%
Dec 31, 2022	72.90B	71.57B	5,415.83%
Dec 31, 2021	1.32B	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.